- Veradermics soars on positive data for baldness treatment<figure><div><img src="https://imgproxy.divecdn.com/_dT9zKJsCoS0jrFraV8Vdkcut5aCVtKPN0y1PuLlKnE/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMTUwMzE2NTA1LmpwZ…BioPharma Dive · 2mo ago↗ source
- Lilly to buy startup Ajax in bid for a better JAK drug<p>Worth up to $2.3 billion overall, the deal hands Lilly a drug designed to address the weaknesses of a class of medicines used to treat myelofibrosis and other diseases.</p>BioPharma Dive · 2mo ago↗ source
- Intellia CRISPR drug succeeds in late-stage study against rare swelling disorder<p>The findings position Intellia to bring to market the first “in vivo” gene editing medicine, though the therapy’s commercial potential remains the source of intense investor de…